Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip R Johnson

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Nature Medicine|May 19, 2009
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeysPhilip R Johnson, Bruce C Schnepp, Jianchao Zhang, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2020
Protection against SIV in Rhesus Macaques Using Albumin and CD4-Based Vector-Mediated Gene TransferSergei Spitsin, Bruce C Schnepp, Mary J Connell, et al.
Science (New York, N.Y.)|June 1, 2013
Accelerating next-generation vaccine development for global disease preventionWayne C Koff, Dennis R Burton, Philip R Johnson, et al.
Journal of Virology|November 12, 2005
Molecular characterization of adeno-associated viruses infecting childrenChun-Liang Chen, Ryan L Jensen, Bruce C Schnepp, et al.
Vaccine|July 12, 2005
Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660Robert E Johnston, Philip R Johnson, Mary J Connell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 29, 2025
Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generationJames I Andorko, Ronnie M Russell, Bruce C Schnepp, et al.
Journal of Virology|December 23, 2004
Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaquesPhilip R Johnson, Bruce C Schnepp, Mary J Connell, et al.
Physical Review Letters|February 9, 2005
Spectroscopy of three-particle entanglement in a macroscopic superconducting circuitHuizhong Xu, Frederick W Strauch, S K Dutta, et al.
Journal of Virology|May 14, 2004
Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodiesNancy L Haigwood, David C Montefiori, William F Sutton, et al.
Nature Immunology|December 17, 2005
HIV vaccine design: insights from live attenuated SIV vaccinesWayne C Koff, Philip R Johnson, David I Watkins, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Nature Medicine|May 19, 2009
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeysPhilip R Johnson, Bruce C Schnepp, Jianchao Zhang, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2020
Protection against SIV in Rhesus Macaques Using Albumin and CD4-Based Vector-Mediated Gene TransferSergei Spitsin, Bruce C Schnepp, Mary J Connell, et al.
Science (New York, N.Y.)|June 1, 2013
Accelerating next-generation vaccine development for global disease preventionWayne C Koff, Dennis R Burton, Philip R Johnson, et al.
Journal of Virology|November 12, 2005
Molecular characterization of adeno-associated viruses infecting childrenChun-Liang Chen, Ryan L Jensen, Bruce C Schnepp, et al.
Vaccine|July 12, 2005
Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660Robert E Johnston, Philip R Johnson, Mary J Connell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 29, 2025
Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generationJames I Andorko, Ronnie M Russell, Bruce C Schnepp, et al.
Journal of Virology|December 23, 2004
Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaquesPhilip R Johnson, Bruce C Schnepp, Mary J Connell, et al.
Physical Review Letters|February 9, 2005
Spectroscopy of three-particle entanglement in a macroscopic superconducting circuitHuizhong Xu, Frederick W Strauch, S K Dutta, et al.
Journal of Virology|May 14, 2004
Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodiesNancy L Haigwood, David C Montefiori, William F Sutton, et al.
Nature Immunology|December 17, 2005
HIV vaccine design: insights from live attenuated SIV vaccinesWayne C Koff, Philip R Johnson, David I Watkins, et al.
Pageof 4